These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3436350)

  • 1. Attempts to increase intratumoral blood flow in the rat solid Walker 256 tumor by the use of the perfluorocarbon emulsion fluosol-DA.
    Klubes P; Hiraga S; Cysyk RL; Owens ES; Blasberg RG
    Eur J Cancer Clin Oncol; 1987 Dec; 23(12):1859-67. PubMed ID: 3436350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increases in brain tumor and cerebral blood flow by blood-perfluorochemical emulsion (Fluosol-DA) exchange.
    Hiraga S; Klubes P; Owens ES; Cysyk RL; Blasberg RG
    Cancer Res; 1987 Jun; 47(12):3296-302. PubMed ID: 3581070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipyrine kinetics following partial blood exchange with Fluosol-DA in the rat.
    Shrewsbury RP; White SG; Pollack GM; Wargin WA
    J Pharm Pharmacol; 1986 Dec; 38(12):883-7. PubMed ID: 2880960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma enzyme concentrations in response to blood substitution with perfluorocarbon emulsion in the conscious rat.
    Lowe KC; McNaughton DC
    Experientia; 1986 Dec; 42(11-12):1228-31. PubMed ID: 3780945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in intravascular fluid composition following blood replacement with perfluorocarbon emulsion in the rat.
    Lowe KC; McNaughton DC; Hardy RN
    Klin Wochenschr; 1985 Oct; 63(19):1028-34. PubMed ID: 4068605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A perfluorochemical emulsion as an oxygen carrier.
    Yokoyama K; Suyama T; Okamoto H; Watanabe M; Ohyanagi H; Saitoh Y
    Artif Organs; 1984 Feb; 8(1):34-40. PubMed ID: 6703924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a perfluorocarbon emulsion, Fluosol-DA, on rat lymphoid tissue and immunological competence.
    Bollands AD; Lowe KC
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 85(2):309-12. PubMed ID: 2879690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygenation effect of fluosol-DA on hypoxic tumor tissue and retention of PFCs in the tumor-bearing rats.
    Watanabe M; Okamoto H; Ohyanaqi H; Saitoh Y; Yano K; Tsuda Y; Ueda Y; Yokoyama K
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):547-56. PubMed ID: 3140922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of a 35% fluorocarbon emulsion.
    Gould SA; Sehgal LR; Rosen AL; Langdale LA; Sehgal HL; Krause L; Moss GS
    J Trauma; 1983 Aug; 23(8):720-4. PubMed ID: 6887290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a transfusion with a blood substitute (Fluosol-DA, 20%) on cerebral circulation in the monkey.
    Nagasawa S; Handa H; Naruo Y; Oda Y; Yonekawa Y; Takebe Y
    Neurol Res; 1981; 3(3):237-50. PubMed ID: 6122175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of varying extents of Fluosol-DA or normal saline haemodilution on the dose dependent kinetics of phenytoin in the rat.
    Shrewsbury RP; Oliver SR; Lewis LM; Anderson WT; White LG
    J Pharm Pharmacol; 1989 Aug; 41(8):582-4. PubMed ID: 2571710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to determine heparin concentrations in plasma containing Fluosol-DA using an analytical kit.
    Shrewsbury RP; White LG
    Clin Chim Acta; 1989 Feb; 179(3):347-8. PubMed ID: 2714008
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of Fluosol-DA on oxygen availability in focal cerebral ischemia.
    Sutherland GR; Farrar JK; Peerless SJ
    Stroke; 1984; 15(5):829-35. PubMed ID: 6433517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions.
    Tokioka H; Miyazaki A; Fung P; Rajagopalan RE; Kar S; Meerbaum S; Corday E; Drury JK
    Circulation; 1987 Feb; 75(2):473-81. PubMed ID: 2948736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of moderate haemodilution with Fluosol-DA or normal saline on indocyanine green and (+)-propranolol kinetics.
    Shrewsbury RP; Lewis LM; Oliver SR; Womble CL
    J Pharm Pharmacol; 1987 Aug; 39(8):592-8. PubMed ID: 2888848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a perfluorocarbon emulsion (Fluosol-DA) on reticuloendothelial system clearance function.
    Castro O; Nesbitt AE; Lyles D
    Am J Hematol; 1984 Jan; 16(1):15-21. PubMed ID: 6695906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorocarbon emulsion prevents eicoasanoid release in skeletal muscle ischemia and reperfusion.
    Gennaro M; Mohan C; Ascer E
    Cardiovasc Surg; 1996 Jun; 4(3):399-404. PubMed ID: 8782946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%).
    Tremper KK; Lapin R; Levine E; Friedman A; Shoemaker WC
    Crit Care Med; 1980 Dec; 8(12):738-41. PubMed ID: 7449405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluosol-DA infusion on pulmonary vascular permeability in the dog lung.
    Hall JE; Ehrhart IC; Hofman WF
    J Trauma; 1986 May; 26(5):432-7. PubMed ID: 3084806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxic effects of oxygen transport media in the isolated rat kidney.
    Millis RM; Barber JD; Anderson WA; Gold AJ; Storm CB; Reindorf CA
    Proc Soc Exp Biol Med; 1985 Apr; 178(4):643-7. PubMed ID: 3983140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.